187 filings
Page 2 of 10
6-K
IMAB
I-Mab
22 Sep 23
Current report (foreign)
4:01pm
6-K
IMAB
I-Mab
17 Aug 23
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates
6:52am
UPLOAD
IMAB
I-Mab
14 Aug 23
Letter from SEC
12:00am
CORRESP
IMAB
I-Mab
7 Aug 23
Correspondence with SEC
12:00am
UPLOAD
IMAB
I-Mab
27 Jul 23
Letter from SEC
12:00am
144
Hayslip John
11 Jul 23
Notice of proposed sale of securities
6:17am
144
Zhu Andrew
5 Jul 23
Notice of proposed sale of securities
8:39am
144
Tang Weimin
5 Jul 23
Notice of proposed sale of securities
8:34am
144
Li Richard Cheng
5 Jul 23
Notice of proposed sale of securities
8:22am
SC 13D/A
IMAB
I-Mab
30 Jun 23
I-Mab / HHLR ADVISORS ownership change
4:05pm
6-K
IMAB
I-Mab
22 Jun 23
I-Mab Announces the Appointment of Raj Kannan as CEO
8:40am
6-K
IMAB
I-Mab
26 May 23
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC
6:02am
144
Yeh Richard
1 May 23
Notice of proposed sale of securities
8:45am
6-K
IMAB
I-Mab
1 May 23
Current report (foreign)
7:36am
6-K
IMAB
I-Mab
1 May 23
Current report (foreign)
7:06am
20-F
2022 FY
IMAB
I-Mab
Annual report (foreign)
1 May 23
6:55am
6-K
IMAB
I-Mab
25 Apr 23
I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China
9:02am
6-K
IMAB
I-Mab
25 Apr 23
I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon
6:01am
6-K
IMAB
I-Mab
3 Apr 23
Current report (foreign)
6:44am
6-K
IMAB
I-Mab
31 Mar 23
Current report (foreign)
6:53am